Sino Biopharm (P Chi Dividend yield

Sino Biopharm (P Chi is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Sino Biopharm (P Chi is a company from China, and his stocks are publicly traded.

Sino Biopharm (P Chi stock dividend

Sino Biopharm (P Chi paid a total dividend of 2,257 million HKD last year, for a market value of 56,051 millions (Market Cap 28,943 millions). Sino Biopharm (P Chi dividend per share is 0.12 HKD, and his stock market price 2.98 HKD.

According to the chart below, where dividend yield is displayed, Sino Biopharm (P Chi has a dividend yield of 4.03%, which is higher than the amount offered by both the market average and companies from China. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Sino Biopharm (P Chi stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high China dividend stocks list.

Sino Biopharm (P Chi Dividend Payout

About the ability of Sino Biopharm (P Chi to maintain his current dividend of HKD 0.12 per share, an amount that accounts for 4.03%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Sino Biopharm (P Chi payout on ernings is currently 75.00%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Sino Biopharm (P Chi can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Sino Biopharm (P Chi is HKD 0.45 per share, which is higher than the dividend per share paid by the company of HKD 0.12, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Sino Biopharm (P Chi, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Sino Biopharm (P Chi Dividend History

Below you will find a table with the historical evolution of Sino Biopharm (P Chi's dividend stock, both in percentage and in HKD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	HKD	Paypout	Shares*
Present	4.03%	0.12	75.00%	18,809
2022	2.19%	0.10	10.53%	18,831
2021	1.83%	0.10	47.62%	18,862
2020	1.07%	0.08	36.36%	18,873
2019	0.92%	0.10	10.87%	12,588
2018	1.29%	0.07	35.00%	12,638
2017	0.51%	0.07	26.92%	7,412
2016	1.03%	0.05	20.83%	7,435
2015	0.55%	0.04	19.05%	7,435

*In millions

Then you can see the evolution of Sino Biopharm (P Chi dividend stock, and compare it with the average of China stocks and that of the Pharmaceuticals and Biotechnology stocks.

Sino Biopharm (P Chi Stock performance

Finally, last moth Sino Biopharm (P Chi showed a return of -15.30% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -28.00% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.